Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 2 - Caught on Camera

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform.

Benzinga

Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost

On Tuesday, Cathie Wood-led Ark Invest executed a significant trade involving Tempus AI Inc (NASDAQ:TEM).

Benzinga

3 Heavily Shorted Stocks That Could Prove the Bears Wrong

Bearish investors are hammering these three stocks with short selling. However, all three have promising developments on their side that bears may be missing.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Tempus AI Expands Into Digital Pathology With Paige Acquisition

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology.

Benzinga

Cathie Wood's $21 Million Tuesday Move: Peter Thiel's Crypto Play Gets Boost In Ark Portfolio

Cathie Wood-led Ark Invest made significant trades on Tuesday with notable activity in Bullish (NYSE:BLSH), Robinhood Markets Inc. (NASDAQ:HOOD), and Tempus AI Inc. (NASDAQ:TEM).

Benzinga

Trump Says Nancy Pelosi Traded On Inside Information—Her 2025 Portfolio Outperforms S&P 500 Thanks To These 4 Stocks

President Donald Trump has accused former House Speaker Nancy Pelosi of trading on “inside information” after her portfolio’s returns reportedly outperformed the SP 500 in 2025.

Benzinga

MarketBeat Week in Review – 08/11 - 08/15

Stocks continued to rise despite conflicting inflation data; the trend is still bullish, but investors should expect volatility heading into September

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?

Tempus AI fired on all cylinders in Q2, and Morgan Stanley upgraded the stock. What is the near and long-term outlook for this name, up 89% in 2025?

MarketBeat

Stocks Rally on Positive Earnings and Hopes for an End to Russia-Ukraine War

The S&P 500 Index ($SPX ) (SPY ) today is up +0.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.70%. September E-mini S&P futures (ESU25 ) are up +0.54%, and September E-mini Nasdaq futures...

Barchart

Stocks Supported by Robust Earnings and Rate Cut Hopes

The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. September E-mini S&P futures (ESU25 ) are up +0.37%, and September E-mini Nasdaq futures...

Barchart

Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday.

Benzinga

S&P Futures Gain as Investors Weigh Trump’s Fed Governor Pick; Gold Futures Jump on Tariff Report

September S&P 500 E-Mini futures (ESU25) are trending up +0.32% this morning, capping a week dominated by tariff and geopolitical developments, as well as a wave of earnings, with investors weighing U.S. President Donald Trump’s efforts to tighten his grip on the Federal Reserve.

Barchart

Tempus AI Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Tempus AI, Inc. (NASDAQ:TEM) will release earnings results for the second quarter before the opening bell on Friday, Aug. 8.

Benzinga

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Imagine this: a hospital conference room, lights low, filled with decision-makers. A sales representative clicks through slides driven by Palantir Technologies’ (NASDAQ:PLTR) Foundry platform, highlighting real-time data integration and pinpoint analytics that would make Pharma RD from the past look like it’s still sending lab results by fax. Down the…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cathie Wood's Ethereum Double-Down: Ark Bets $7.9 Million On ETH-Staking ETF Buy While Selling Coinbase At Highs

On Wednesday, Cathie Wood-led Ark Invest executed significant trades, including substantial purchases in Tempus AI Inc. (NASDAQ:TEM), NVIDIA Corp. (NASDAQ:NVDA), 3iQ Ether Staking ETF (ETHQ.U) and Coinbase Global Inc. (NASDAQ:COIN).

Benzinga

Tempus AI Stock Is Rising Wednesday: What's Happening?

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction software.

Benzinga

Cathie Wood Bets Another $1 Million On Tempus AI Despite Jim Cramer's Doubts, Dumps Crypto Stocks As Bitcoin Hits Fresh New Highs

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:TEM), Coinbase Global Inc. (NASDAQ:COIN), Robinhood Markets Inc. (NASDAQ:HOOD), and Block Inc. (NYSE:XYZ).

Benzinga

Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

Apple Inc's (NASDAQ:AAPL) massive $60+ billion cash pile is once again in the spotlight – and with rivals racing ahead in AI, investors are wondering: is it finally time for Apple to make a bold move?

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cathie Wood Dumps Jack Dorsey's Block As Bitcoin Flirts With All-Time Highs, Bets $8.8 million On Tempus AI

On Wednesday, the Cathie Wood-led Ark Invest made a significant move by purchasing a substantial number of shares in Tempus AI Inc. (NASDAQ:TEM) and selling shares of Block Inc. (NYSE:XYZ). The trades were executed through the ARKG and ARKK ETFs.

Barchart

Short Sellers Are Taking Aim at Buy-Rated Tempus AI. Should You Buy TEM Stock Here?

Tempus AI stock fell over 19% after Spruce Point Capital released a short report. Can TEM stock recover?

MarketBeat

Tempus AI Stock: Time to Double Down or Cut and Run?

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

MarketBeat

3 Hot New IPOs Defying the 2025 Market Slump

Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.

International Business Times UK

Nancy Pelosi's 2025 Stock Buys Worth $1.95M are Deep in Red, Some as Much as 57%

Former House Speaker Nancy Pelosi purchased call option contracts of companies, including Alphabet, Amazon, Nvidia, Vistra Corp, and Tempus AI, in January.

Barchart

Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now?

MarketBeat

Tempus AI Is a Buy, If You Can Handle the Volatility

Tempus AI is well-positioned to capitalize on its extensive clinical data database. It can provide personalized treatment for hard-to-treat illness.

1 2 3

People

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.